1Departments of Pediatrics and Anesthesiology Critical Care Medicine, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA. 2Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Pediatr Crit Care Med. 2014 Jan;15(1):1-6. doi: 10.1097/PCC.0000000000000011.
High-flow humidified nasal cannula is often used to provide noninvasive respiratory support in children. The effect of high-flow humidified nasal cannula on effort of breathing in children has not been objectively studied, and the mechanism by which respiratory support is provided remains unclear. This study uses an objective measure of effort of breathing (Pressure. Rate Product) to evaluate high-flow humidified nasal cannula in critically ill children.
Prospective cohort study.
Quaternary care free-standing academic children's hospital.
ICU patients younger than 18 years receiving high-flow humidified nasal cannula or whom the medical team planned to extubate to high-flow humidified nasal cannula within 72 hours of enrollment.
An esophageal pressure monitoring catheter was placed to measure pleural pressures via a Bicore CP-100 pulmonary mechanics monitor. Change in pleural pressure (ΔPes) and respiratory rate were measured on high-flow humidified nasal cannula at 2, 5, and 8 L/min. ΔPes and respiratory rate were multiplied to generate the Pressure.Rate Product, a well-established objective measure of effort of breathing. Baseline Pes, defined as pleural pressure at end exhalation during tidal breathing, reflected the positive pressure generated on each level of respiratory support.
Twenty-five patients had measurements on high-flow humidified nasal cannula. Median age was 6.5 months (interquartile range, 1.3-15.5 mo). Median Pressure,Rate Product was lower on high-flow humidified nasal cannula 8 L/min (median, 329 cm H2O·min; interquartile range, 195-402) compared with high-flow humidified nasal cannula 5 L/min (median, 341; interquartile range, 232-475; p = 0.007) or high-flow humidified nasal cannula 2 L/min (median, 421; interquartile range, 233-621; p < 0.0001) and was lower on high-flow humidified nasal cannula 5 L/min compared with high-flow humidified nasal cannula 2 L/min (p = 0.01). Baseline Pes was higher on high-flow humidified nasal cannula 8 L/min than on high-flow humidified nasal cannula 2 L/min (p = 0.03).
Increasing flow rates of high-flow humidified nasal cannula decreased effort of breathing in children, with the most significant impact seen from high-flow humidified nasal cannula 2 to 8 L/min. There are likely multiple mechanisms for this clinical effect, including generation of positive pressure and washout of airway dead space.
高流量湿化鼻导管常用于为儿童提供无创性呼吸支持。高流量湿化鼻导管对儿童呼吸用力的影响尚未得到客观研究,其提供呼吸支持的机制仍不清楚。本研究使用呼吸用力的客观测量指标(压力.速率乘积)来评估危重症儿童的高流量湿化鼻导管。
前瞻性队列研究。
四所独立的学术儿童医院。
年龄小于 18 岁的 ICU 患者,在入组后 72 小时内接受高流量湿化鼻导管或医疗团队计划将其从气管插管转为高流量湿化鼻导管。
放置食管压力监测导管,通过 Bicore CP-100 肺力学监测仪测量胸膜压力。在 2、5 和 8 L/min 时,测量高流量湿化鼻导管上的胸膜压力变化(ΔPes)和呼吸频率。将 ΔPes 和呼吸频率相乘,生成压力.速率乘积,这是一种经过充分验证的呼吸用力的客观测量指标。基线 Pes 定义为潮气呼吸末期的胸膜压力,反映了在每个呼吸支持水平上产生的正压。
25 名患者在高流量湿化鼻导管上进行了测量。中位年龄为 6.5 个月(四分位距,1.3-15.5 mo)。与高流量湿化鼻导管 5 L/min(中位数,341;四分位距,232-475;p=0.007)或高流量湿化鼻导管 2 L/min(中位数,421;四分位距,233-621;p<0.0001)相比,高流量湿化鼻导管 8 L/min 的压力.速率乘积较低,而与高流量湿化鼻导管 5 L/min 相比,高流量湿化鼻导管 2 L/min 的压力.速率乘积较低(p=0.01)。与高流量湿化鼻导管 2 L/min 相比,高流量湿化鼻导管 8 L/min 的基线 Pes 较高(p=0.03)。
增加高流量湿化鼻导管的流速可降低儿童的呼吸用力,从高流量湿化鼻导管 2 到 8 L/min 时影响最大。这种临床效果可能有多种机制,包括产生正压和冲洗气道死腔。